Genocea Biosciences

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch GNCA and buy or sell other stocks, ETFs, and their options commission-free!

About GNCA

Genocea Biosciences, Inc. engages in the development and commercialization of cancer immunotherapies. The firm uses its proprietary technology platform, ATLAS, to identify clinically relevant antigens of T cells based on actual human immune responses. 

CEO
Chip Clark, MBA
CEOChip Clark, MBA
Employees
—
Employees—
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2006
Founded2006
Employees
—
Employees—

GNCA Key Statistics

Market cap
100.00
Market cap100.00
Price-Earnings ratio
—
Price-Earnings ratio—
Dividend yield
—
Dividend yield—
Average volume
125.00
Average volume125.00
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$0.0088
52 Week high$0.0088
52 Week low
—
52 Week low—

Stock Snapshot

Genocea Biosciences(GNCA) stock is priced at $2.26, giving the company a market capitalization of 100.

Genocea Biosciences(GNCA) stock opened on 2026-07-16 at —. The price climbed to — and dipped to —.

The Genocea Biosciences(GNCA)'s current trading volume is 0, compared to an average daily volume of 125.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.